Type
. Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice. Infection and immunity. 1983;40(3):1096-103.
Type
. [Circulating immune complexes in lepromatous leprosy patients]. Vestnik dermatologii i venerologii. 1983;(5):11-4.
Type
. [Antibacterial treatment of bacteria-abundant leprosy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1983;34(5):203-8.
Type
. Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria. Clinical and experimental immunology. 1983;52(2):441-8.
Type
. Prevalence survey of secondary dapsone resistance in leprosy in Kancheepuram and Tiruvannamalai control units of Tamil Nadu. Leprosy in India. 1983;55(2):222-30.
Type
. Lepromatous leprosy in man; depth of the cellular infiltrate and bacillary mass in relation to the possibility of transmission of leprosy by biting arthropods. Annals of tropical medicine and parasitology. 1983;77(2):187-93.
Type
. Can the leper change his spots? The iconography of leprosy. Part II. The American Journal of dermatopathology. 1983;5(2):173-86.
Type
. Hansen's disease: Dr. Freerksen's reply to Dr. Vellut. The Nursing journal of India. 1983;74(4):96-7.
Type
. Persistence of Mycobacterium leprae in the peripheral nerve. The Indian journal of medical research. 1983;77:420-2.
Type
. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients. Clinical and experimental immunology. 1983;52(1):107-14.